Skip to main content

Advertisement

SpringerLink
Log in

The relationship between local recurrence and death in early-stage breast cancer

  • Epidemiology
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

To examine the relationship between local recurrence and breast cancer mortality in women with early-stage breast cancer. We studied 1675 women with stage 0 (DCIS), stage I or stage II breast cancer who were treated with breast-conserving surgery at Women’s College Hospital between 1987 and 2009. For each patient, we obtained information on age at diagnosis, tumour size, lymph node status, tumour grade, lymphovascular invasion, oestrogen receptor status, progesterone receptor status, HER2 status and treatments received (radiotherapy, chemotherapy and tamoxifen). Patients were followed from the date of diagnosis until local recurrence, death from breast cancer or the date of last follow-up. We used the Kaplan–Meier method to estimate 15-year local recurrence-free and breast cancer-specific survival rates for each stage at diagnosis. For each stage, the two rates were compared. After a mean follow-up of 13.1 years, 243 women (14.5 %) experienced a local recurrence and 281 women (16.8 %) died of breast cancer. The 15-year actuarial rate of local recurrence was 16 % for women with DCIS, 15 % for women with stage I cancer and 16 % for women with stage II cancer. The 15-year breast cancer-specific mortality rate was 3 % for women with DCIS, 10 % for women with stage I breast cancer and 30 % for women with stage II breast cancer. After experiencing a local recurrence, the 15-year breast cancer mortality rate was 16 % for women with DCIS, 32 % for women with stage I breast cancer and 59 % for women with stage II breast cancer. Across the spectrum of the early stages of breast cancer, the risk of local recurrence does not correlate with the risk of death from breast cancer. After local recurrence, the risk of death from breast cancer depends on the initial stage at diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Health Quality Ontario (2010) Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis. Ont Health Technol Assess Ser 10(23):1–57

    Google Scholar 

  2. Wapnir I, Dignam J, Fisher B et al (2011) Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 103:478–488

    Article  PubMed  PubMed Central  Google Scholar 

  3. Anderson S, Wapnir I, Dignam J et al (2009) Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol 27:2466–2473

    Article  PubMed  PubMed Central  Google Scholar 

  4. Wapnir I, Anderson S, Mamounas E et al (2006) Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project protocols of node-positive breast cancer. Clin Oncol 24:2028–2037

    Article  Google Scholar 

  5. Rakovitch E, Nofech-Mozes S, Hanna W et al (2015) A population-based validation score of the DCIS Score predicting recurrence risk in individuals treated by breast conserving surgery alone. Breast Cancer Res Treat 152:389–398

    Article  PubMed  PubMed Central  Google Scholar 

  6. Liu F, Shi W, Done S et al (2015) Identification of a low-risk luminal A breast cancer cohort that may not benefit from breast radiotherapy. JCO 33(18):2035–2040

    Article  Google Scholar 

  7. Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347(16):1233–1241

    Article  PubMed  Google Scholar 

  8. McGale P, Taylor C, Correa C et al (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 383:2127–2135

    Article  PubMed  CAS  Google Scholar 

  9. Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P (2015) Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol 1(7):888–896

    Article  PubMed  Google Scholar 

  10. Falk R, Hofvind S, Skaane P, Haldorsen T (2011) Second events following ductal carcinoma in situ of the breast: a register-based cohort study. Breast Cancer Res Treat 129:929–938

    Article  PubMed  CAS  Google Scholar 

  11. Warnberg F, Garmo H, Emdin S et al (2014) Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS trial. J Clin Oncol 32:3613–3618

    Article  PubMed  Google Scholar 

  12. Donker M, Litiere S, Werutsky G et al (2013) Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. J Clin Oncol 31:4054–4059

    Article  PubMed  Google Scholar 

  13. Holzel D, Emeny R, Engel J (2011) True local recurrences do not metastasize. Cancer Metastasis Rev 30:161–176

    Article  PubMed  Google Scholar 

  14. Dent R, Valentini A, Hanna W et al (2014) Factors associated with breast cancer mortality after local recurrence. Curr Oncol 21(3):418–425

    Article  Google Scholar 

  15. Engel J, Eckel R, Kerr J et al (2003) The process of metastasisation for breast cancer. Eur J Cancer 39:1794–1806

    Article  PubMed  CAS  Google Scholar 

  16. Veronesi U, Marubini E, Del Vecchio M et al (1995) Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 87:19–27

    Article  PubMed  CAS  Google Scholar 

  17. Park S, Han W, Kim J et al (2015) Risk factors associated with distant metastasis and survival outcomes in breast cancer patients with locoregional recurrence. J Breast Cancer 18(2):160–166

    Article  PubMed  PubMed Central  Google Scholar 

  18. Yi M, Bucholz T, Meric-Bernstam F et al (2011) Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning. Ann Surg 253:572–579

    Article  PubMed  PubMed Central  Google Scholar 

  19. Millar E, Graham P, O’Toole S et al (2009) Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. J Clin Oncol 27(28):4701–4708

    Article  PubMed  Google Scholar 

  20. Kummel A, Kummel S, Barinoff J et al (2015) Prognostic factors for local, loco-regional and systemic recurrence in early-stage breast cancer. Geburtshilfe Frauenheilkd 75(7):710–718

    Article  PubMed  PubMed Central  Google Scholar 

  21. De Mascarel I, MacGrogan G, Mathoulin-Pelissier S, Soubeyran I, Picot V, Coindre JM (2002) Breast ductal carcinoma in situ with microinvasion. A definition supported by a long-term study of 1248 serially sectioned ductal carcinomas. Cancer 94:2134–2142

    Article  PubMed  Google Scholar 

  22. Parikh R, Haffty B, Lannin D, Moran M (2012) Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation. Int J Radiat Oncol Biol Phys 82:7–13

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Katarzyna Jerzak, Javaid Iqbal and Vasily Giannakeas for helpful discussions.

Author information

Authors and Affiliations

  1. Women’s College Research Institute, 76 Grenville Street, Toronto, ON, M5S 1B1, Canada

    Victoria Sopik, Ping Sun & Steven A. Narod

  2. Sunnybrook Health Sciences Centre, Toronto, Canada

    Sharon Nofech-Mozes

Authors
  1. Victoria Sopik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sharon Nofech-Mozes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ping Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Steven A. Narod
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven A. Narod.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 19 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sopik, V., Nofech-Mozes, S., Sun, P. et al. The relationship between local recurrence and death in early-stage breast cancer. Breast Cancer Res Treat 155, 175–185 (2016). https://doi.org/10.1007/s10549-015-3666-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-015-3666-y

Keywords

Search

Navigation